INTRODUCTION
The explosion of obesity worldwide is a considerable threat for social health and related costs (Raymond et al. 2006) . In Brazil its prevalence raised from 4.2 to 14.3% in a period of 1975 to 1997 (Popkin 2004 , while in countries like USA this number amounts to 40%.
Overweight and obesity are the soil for most cases of cardiovascular diseases and type 2 diabetes, since about 85% of diabetic patients have, at least, overweight. Appearing well before type 2 diabetes and being, in most cases, related to metabolic syndrome, obesity becomes a preferential target for future new therapies facing the Correspondence to: Professor Eliete Bouskela E-mail: eliete_bouskela@yahoo.com.br relatively poor success rate of diet or dieting. However, as will be seen, very recent findings tend to change our views, questioning the classical (oversimplified?) view that overweight and obesity are automatically linked to increased mortality.
Similarly, young obese adults already exhibit aortic stiffness (Wildman et al. 2003) . However, the most important discovery in recent years, using partly retrospective studies, is the specific relationship between cardiovascular diseases and some degrees or forms of obesity. These findings, which appear homogeneous, may drastically change our views as to what to treat. Indeed two major orientations emerge from these findings: 1) the prominent importance of abdominal vs. ectopic fat accumulation;
2) the "subpopulations" of overweight/obese patients and their relative risk levels for cardiovascular diseases.
Several studies have shown the particular importance of visceral fat accumulation: men with 'hypertriglyceridemic waist' have a 20 fold increase in cardiovascular disease risk (Despres et al. 2001 ) and the severity of metabolic syndrome and risk for cardiovascular diseases are increasing with higher amounts of abdominal fat (Mori et al. 2006 ). This connection is active independently of other factors (Despres 2006) . Reasons for this close association are discussed elsewhere in this review.
Very recent data show that overweight, high body mass index (BMI, relationship between weight in kg and height in m 2 ) and obesity are general terms with obscure and subtle relationships. Kip and co-workers (Kip et al. 2004 ) have shown that metabolic syndrome, rather than BMI, is linked to coronary artery disease which illustrates one of the main difficulties in understanding mechanisms leading to or aggravating obesity, namely the high number of interfering factors (genetic, acquired or environmental and social) which can bias studies in such patients. Surprisingly, there are data from large scale clinical and epidemiological investigations showing that either underweighted or severely overweighted patients to be the ones at high risk for cardiovascular diseases, whereas mildly overweight and moderately obese were not (Flegal et al. 2005) . A meta-analysis of 40 studies with a total of about 205.000 patients followed for 3.8 years revealed that overweight or obese patients had even a reduced risk for cardiovascular diseases, with only severely obese subjects being at increased risk (RomeroCorral et al. 2006 ). This challenging result is corroborated by a study in 7767 patients with heart failure: while all-cause mortality was 45% in underweight patients, it was only 28% in obese patients, a number even lower than the one found for healthy subjects (Curtis et al. 2005) . Another study showed that, in the absence of confounding factors such as smoking, obese patients (n = 22025 followed for 23 years) showed a low risk association with cardiovascular diseases (Jonsson et al. 2002) . All recent investigations identify the abdominal fat as the "bad player", thereby confirming previous observations about the determinant role of even 1 kg of intra-abdominal fat loss for improving insulin resistance. Abdominal fat is highly lipolytic and secretes many cytokines and inflammatory mediators responsible for peripheral insulin resistance. This effect is far less important for peripheral subcutaneous fat. Overweight and obesity therefore will have to be considered differently from before, as absolute amount of excessive weight appears less important than its body localization. Thus a few intra-abdominal kilograms of fat are much more harmful than more kilograms distributed over the whole body: as an example, subjects may develop ectopic obesity instead of abdominal one, accumulating subcutaneous fat (which is less harmful), thereby affording for a paradoxical protection (Cherian and Santoro 2006) . Moreover the vast majority of type 2 diabetic patients are overweight or obese but conversely the burden of diabetes expected from the enormous number of obese individuals has not yet been observed. These new and partly provocative aspects then suggest that obesity might no longer be viewed as a general medical threat but rather give priority to properly identification of subjects presenting visceral fat accumulation, which can easily and conveniently be determined by simple waist circumference or waist/hip ratio measurements. As a consequence, therefore, the health problem caused by obesity may become more important essentially due to high and growing number of obese patients rather than because of morbidity on its own (Gibbs 2005) .
OBESITY: A COMPLEX STATE TO INVESTIGATE
Obesity is a multifactorial disease, by origin (hereditary and social factors) and clinical picture: a vast majority of obese adult subjects have metabolic syndrome, being most of them insulin resistant (IR). Insulin resistance
itself is a major threat for developing diabetes and/or cardiovascular diseases. These frequent metabolic and regulatory derangements bias the interpretation of many investigations while therapeutic concepts require more than just correlations. Ideally, therefore, studies aiming to identify mechanisms responsible for obesity should be performed either early in life in selected populations or in patients with uncomplicated obesity. Interestingly a recent estimation made in Italy, revealed that 27% of obese patients had uncomplicated obesity (Iacobellis et al. 2005 ), a number which looks surprisingly high. Unfortunately the medical awareness of this situation is still low and few data are available from this particular subgroup of obese patients. The existing ones show that flow-mediated dilatation (FMD), a well-accepted clinical test to investigate endothelial-dependent vascular reactivity, is reduced in uncomplicated obesity and linked to insulin resistance (Pasimeni et al. 2006) . Also in these patients, body fat distribution determines endothelial dysfunction (ED) which is linked to elevated abdominal fat, whereas metabolic parameters, blood pressure and body weight did not correlate with it (Arcaro et al. 1999 , Suh et al. 2005 . These findings suggest that endothelial dysfunction, a predictor of coronary and peripheral arterial diseases, is possibly inherent to obesity, although the presence of insulin resistance precludes any definitive conclusions. Clearly, more clinical studies targeting uncomplicated obese patients should be encouraged.
OBESITY, VASCULAR REACTIVITY, MICROCIRCULATION: WHAT IS MEASURED?
Vascular reactivity is a prominent physiological mechanism adapting organ and local blood flow to acute and chronic tissue requirements. Vascular dysfunction, as analyzed by global or specific local techniques, not only depends on both structural and functional changes in feeding arteries but also largely on the microcirculation. In fact, microvessels are the true site of blood/tissue nutrition and exchange; accordingly they represent the largest part of vessels in the body and are subjected to multiple, fine tuning regulations.
Larger arteries are conduit vessels, mid-sized and small arteries are resistance vessels (mainly controlling blood pressure) while terminal arterioles (< 50µm diameter), capillaries (diameter of 5-6µm) organized in units, and venules represent the microvascular bed. Precapillary arterioles feed capillary units formed by about 15 capillaries each and finely regulate the qualitative and quantitative aspects of blood flow through these units. This regulation is ensured by completely specific, essentially local nervous and humoral control systems aimed at adapting, in the most economical manner, the blood flow to local metabolic requirements of surrounding tissue.
Global investigations of vascular function, although comprising the microcirculation, also encompass large and mid-sized vessels in classical tests such as reactive hyperemia to transient ischemia. However, mechanisms underlying physiological regulation of these consecutive vessel segments strongly differ, not only along the vascular tree but also from organ to organ. Therefore the relevance of findings obtained in "in-between" studies is questionable, depending on evaluation of the technique used (ex: venous plethysmography vs. ultrasound) and which tissue is investigated (ex: whole limb vs. skeletal muscle vs. skin).
ENDOTHELIAL DYSFUNCTION
Nitric oxide (NO), considered the main mediator of flow-mediated dilatation, appears to be more representative of large and small arteries than of terminal arterioles (Pohl et al. 2000) . Moreover, while the reactive hyperemia is largely due to NO in skeletal muscle, this is different in the skin (Wong et al. 2003 , Hansell et al. 2004 . Finally the reactive hyperemia response following ischemia of short duration is mainly linked to NO but longer ischemic episodes call for additional mechanisms such as prostaglandins or factors involved in nervous system control of vessels. Altogether flowmediated dilatation, the most widely used technique in clinical studies, has thus a limited relevance and provides essentially valuable information when measurements originate from "within-patient" studies. These differences explain the discrepancy seen in published reports. Recent analyzes showed that flow-mediated dilatation in forearm correlated well with arterial stiffness in other organs (Mitchell et al. 2005) Silber et al. 2005) . Flow-mediated dilatation potentially also results from non-endothelial dilating mechanisms operating in smooth muscle cells; however, since most studies fail to show abnormalities in this part of the vessel wall, flow-mediated dilatation is considered to represent essentially endothelial function. However, because the reactive hyperemia response following an ischemic episode is undoubtedly linked, to a significant extent, to the microcirculation, one should review existing data on endothelial dysfunction in obese subjects.
Abnormalities in flow-mediated dilatation, representing endothelium dysfunction, are linked to obesity independently of hypertension, although most obese patients have at last mild elevations in blood pressure (Higashi et al. 2001) . Endothelial dysfunction has been found in most dedicated studies and again fat distribution has been found to be the main determinant (Hashimoto et al. 1998 , Nestel et al. 1998 , Suh et al. 2005 . Thus waist/hip ratio, a clinical marker representing abdominal obesity, seemed to be better correlated with endothelial dysfunction than BMI (Brook et al. 2001 , Villela et al. 2006 , Weinbrenner et al. 2006 . Other methods use intrabrachial acetylcholine injections (Lind et al. 2002) to induce vasodilatation by other mechanisms than shear stress induced by hyperemia: they confirm a reduction in vasodilating capacity, even in normotensive/normoglycemic obese patients (Van Guilder et al. 2006) . Alternatively, local insulin injections can be used to induce NO-mediated dilatation to further confirm prevailing endothelial dysfunction (Westerbacka et al. 1999) . Interestingly, when overweight, hypertriglyceridemic patients were put on diet, prominent cardiovascular risk factors such as PAI-1 or ICAM-1 were reduced without any significant improvement on flow-mediated dilatation (Clifton et al. 2005 ).
In addition to diminished vasodilatation, increased vasoconstriction can also occur, which may partly explain blunted dilatatory reactions and give rise to false interpretations about defective mechanisms. In patients with upper body obesity, no endothelial dysfunction but enhanced constriction to angiotensin II was reported (Nielsen et al. 2004) . Elevated vasoconstriction may thus blunt vasodilatation in specific tests, possibly giving misleading informations. For example, increased endothelin levels were shown to mask a normal NO production (Mather et al. 2004 , Stepp 2006 .
MICROCIRCULATION: TECHNICAL AND MECHANISTIC SPECIFICITIES
Physiology, biochemistry and pharmacology vary according to vessels size and location. However, the compartment for tissue nutrient delivery, which ultimately determines cell life, is the microcirculation. The correlation between flow-mediated dilatation and microcirculatory variables is a matter of debate (Shamim-Uzzaman et al. 2002 , Hansell et al. 2004 : in the same animal, aortic vasodilatation was normal while small vessels exhibited endothelial dysfunction (Stepp 2006) but another recent study did not find any dysfunction in skin of obese patients, in contrast to what occurs in skeletal muscle (Seywert et al. 2004) . Considering that flow-mediated dilatation does neither entirely nor necessarily represent the microcirculation, direct microcirculatory measurements must also be performed in order to obtain more specifically relevant data for mechanistic interpretations.
The microcirculation can be analyzed non-invasively in humans either by direct intravital capillaroscopy on skin or nailfold, or by laser Doppler measurements. In animal research, these techniques can be used in relevant organs such as skeletal muscle, hamster cheek pouch or mesenterium. Studies in muscle are particularly important in view of the suspected cardinal role of the microcirculation in insulin resistance/ metabolic syndrome.
Animal studies have mainly been performed in obese Zucker rats. Both structural and functional defects are present in the microcirculation of these animals: microvessel permeability to macromolecules is increased (St-Pierre et al. 2006 ) and capillary rarefaction well documented, independently of prevailing hypertension (Frisbee 2005) . Baseline arteriolar diameter was dec reased in a muscle preparation (Frisbee 2003) and sympathetic nervous system activated in these rats (Alvarez et al. 2002) but not subcutaneous fat (Alvarez et al. 2004 ). Due to elevated adrenergic tone and to structural vessel narrowing, the reactive hyperemia response was impaired (Frisbee 2006) . Capillary rarefaction in skeletal muscle was also found in all fibre types in obese patients (Gavin et al. 2005) . Already in normal children, skin microvascular response to acetylcholine is negatively correlated with central adiposity (Khan et al. (4) 2003). Obese children exhibited increased basal cutaneous blood flow but peak capillary blood cell velocity was reduced during the reactive hyperemia response, a finding obviously unrelated to the subject's dyslipidemia (Chin et al. 1999 ). Dilatation to other stimuli affecting the microcirculation was also defective: despite similar increases in blood pressure, responses in skeletal muscle or skin to mental stress were impaired (Agapitov et al. 2002) . Peripheral vasodilatation following an oral glucose load was blunted in obese patients (Baron et al. 1990) , probably due to absence of capillary recruitment to plasma insulin increase in these subjects (DeJongh et al. 2004a , Clerk et al. 2006 . Not only insulin-induced vasodilatation but also insulin passage from blood to tissue may limit hormonal action since in obesity, transendothelial insulin transport was reduced (Sjostand et al. 2005 , Wascher et al. 2000 . In smaller arterioles, vasodilatation is more dependent on EDHF (endothelial-derived hyperpolarizing factor) family mediators than on NO. Although the exact nature of EDHF(s) is obscure, impaired vasodilatation was linked to reduced response of inwardly rectifying potassium channels in humans with visceral obesity (Vigili de Kreutzenberg et al. 2003) .
Microvascular blood flow depends on capillary density, which itself depends on muscle fibre type. Oxidative fibres, requiring more energy consumption, have smaller iameter and are surrounded by more capillaries/fibre than non-oxidative or intermediate fibres. This kind of bias could potentially explain apparent differences in endothelial function between muscle and skin (Seywert et al. 2004 ). Therefore, functional capillary studies in muscle should ideally be accompanied by histochemical determination of fibre type and capillary counting. Data on muscle fibre type composition in obesity are scarce: an increase of type IIb at the expense of type I fibres has been reported (Kriketos et al. 1996) but other obscure mechanisms may operate: after diet, capillary density was increased by 54% whereas muscle fibre type was unchanged (Kern et al. 1999) . Clearly, more investigations in this field would be worthwhile.
HEMORHEOLOGY
Regulation of large and small vessels is partly operated through sensing mechanic forces applied by flowing blood on vessel walls (shear rate, shear stress). Blood flow behaviour is highly dependent on plasma viscosity and blood cell fluidity/stickness. Elevated plasma viscosity is indeed a hallmark of obesity (Cortinovis et al. 1997 , Hernandez et al. 2002 , possibly due to the abnormal lipid profile, present in most of these patients (Aloulou et al. 2006) . Whole blood and plasma viscosity predict intima/media thickness in arteries (Zhu et al. 2005) and, interestingly, both parameters are closely linked to decreased peripheral glucose uptake even in normal subjects (Moan et al. 1994 ). The latter observation supports a role for microcirculation having a causative implication in metabolic syndrome. Erythrocyte deformability is reduced in obesity, potentially hampering flow passage through the capillary bed (Cortinovis et al. 1997) . Triglycerides aggregate red cells, which leads to inhomogeneous flow within the capillary network (Maeda et al. 2006 ).
In conclusion, animal and human studies clearly document highly significant defects in vascular reactivity in all vascular segments. This is particularly relevant for visceral obesity. At the microcirculatory level, both structural and functional defects are observed which combined to hemorheological abnormalities, make impaired microflow likely. Finally one should remember that microcirculation is an integral, sometimes cardinal, part of large vessel diseases (Schwitter et al. 2006) .
MECHANISMS INVOLVED IN MICROCIRCULATORY DISTURBANCES IN OBESITY
Established obesity is a multifactorial pathological situation, encompassing dyslipidemia, hypertension and usually most of the components of insulin resistance and metabolic syndrome. It is thus difficult to discriminate what is really responsible for the defective vascular reaction in obesity. Again, uncomplicated obesity could provide better answers but such data are missing today. If we consider abdominal obesity and the early installation of peripheral insulin resistance, one might suggest that the crosstalk between intra-abdominal fat and skeletal muscle provides some interesting clues.
CIRCULATING MEDIATORS
The last decade has largely established that metabolic syndrome and frequent accumulation of fat in abdomi-
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NICOLAS WIERNSPERGER, PIERRE NIVOIT and ELIETE BOUSKELA nal tissues are accompanied by an inflammatory state: elevated levels of CRP, PAI-1, TNFα, IL-6 and changes in adipokines, produced by fat cells (particularly adiponectin). Several of these mediators are indeed known to produce vascular effects similar to those observed in obesity.
Without detailing this field here, one should nevertheless recall that PAI-1 plays a prominent role in both metabolic and vascular abnormalities linked to metabolic syndrome (Griffiths and Grainger 2006) . PAI-1 is produced by visceral fat, in contrast to subcutaneous fat (Shimomura et al. 1996) . Mice lacking PAI-1 have higher basal metabolic rate and do not develop obesity on a high fat diet (Ma et al. 2004 ). Similar findings are observed when PAI-1 is pharmacologically inhibited (Crandall et al. 2006 ).
In addition to interfering directly with the insulin receptor, TNFα blocks capillary recruitment to insulin, which can cause a decrease of glucose uptake in skeletal muscle fibres and peripheral insulin resistance (Youd et al. 2000 , Ijzerman et al. 2006 ). Interleukin-6, on the other hand, is atherogenic, stimulates the hypothalamohypophyseal axis favouring obesity and blunts NO-induced vasodilatation (Yudkin et al. 2000, Orshal and Khalil 2004) .
Finally it was recently found that fat cells secrete ESM-1 (endothelial cell specific molecule 1), which decreases leukocyte adhesion to vessels and their transendothelial migration (Janke et al. 2006) . The level of this substance is reduced in obesity and by insulin and cortisol. Potentially, therefore, low ESM-1 levels might favour leukocyte activation and oxidative stress.
The past decade has shown the cardinal importance of several adipokines secreted by fat cells, in particular the key role played by adiponectin on metabolic and cardiovascular regulation (Ouchi et al. 2006) . In obese subjects, particularly ones with visceral fat accumulation, adiponectin levels were decreased (Kim et al. 2006) . Low postnatal adiponectin levels correlated inversely with weight gain in children born small for age (Iniguez et al. 2004 ).
Dyslipidemia is a common feature in obesity. Free fatty acids can block capillary recruitment (De Jongh et al. 2004b , Clerk 2002 ) and high fat diet leads to both capillary rarefaction and insulin resistance (Kemppainen et al. 2003 , Nusz et al. 2003 . Presently it is accepted that very early fat deposition in muscle cells is a hallmark of prediabetic insulin resistance (Malenfant et al. 2001) . Some findings suggest that microcirculatory defects, deriving blood supply from nutritive vascular channels, could also explain the intermyofibrillar fat deposition in skeletal muscles (Clerk et al. 2000 ). An elegant hypothesis has recently been proposed, stating that periarteriolar fat, like abdominal fat, might liberate TNFα and thereby block local NO production or sensing ("vasocrine" fat signalling) (Yudkin et al. 2005) .
FROM CAPILLARY FLOW TO INSULIN RESISTANCE
Insulin resistance is usually-but not automatically accompanying obesity. There is little doubt that each of both interact, creating a vicious circle constantly aggravating the metabolic situation. Since microvascular defects can be observed even shortly after birth in subjects at risk for metabolic syndrome (Wiernsperger et al. 2007) , the concept of microvascular disturbances being a primary event leading to insulin resistance has to be addressed. Several recent dedicated reviews on this -yet to be proven-hypothesis can be found (Tooke and Goh 1998 , Wiernsperger 2000 , Hayden and Tyagi 2003 , Tudor et al. 2005 , Matsumoto et al. 2006 . One may just mention here that it makes sense that limited capillary perfusion, whether due to defective recruitment or structural density, subsequently limits the supply of glucose and insulin in skeletal muscle cells, thereby favouring insulin resistance (Wiernsperger et al. 2007) . Indeed it was shown that even in normal individuals, capillary density and insulin sensitivity were correlated (Lillioja et al. 1987 , Marin et al. 1994 . It is of interest that a reduction in muscle capillary density was observed following myocardial infarction or heart failure (Kindig et al. 1999 , Nusz et al. 2003 , two patient populations likely to develop insulin resistance or even diabetes within a couple of years (Pajunen et al. 2005 ). Finally there is still a debate as to whether anteceding capillary rarefaction, as seen in offsprings of hypertensive parents, might be responsible for the later development of hypertension in adulthood (Antonios et al. 2003) .
All these data point to a potentially important and causative role of microcirculation at early steps of metabolic diseases. Obesity is linked with an array of circu-lating and nervous factors expected to impair microflow, potentially resulting in generation or aggravation of metabolic and cardiovascular disturbances. The potential bidirectional link between microcirculation and insulin resistance , however, also raises the question of a causal role of microvascular derangements upstream of overweight/obesity. Therefore, studies in very early states in life of at risk patients would be helpful to answer this important question.
OBESITY: SHOULD WE LOOK BACK?
Investigating the microcirculation in animals or patients prone to develop obesity would (1) reduce the bias represented by very abnormal and complex changes in the metabolic and hormonal milieu encountered in established obesity and (2) allow to identify eventual initial disturbances in microcirculation which could favour the development of it.
ON ORIGINS OF OBESITY
The burden of infant overweight and childhood obesity in westernalized and developing countries has contributed to consider more closely the origins of obesity. It might be inherited, acquired or programmed. During recent years, challenging data have been provided to answer these cardinal questions.
That obesity can be inherited is self-evidence. It is less recognized, however, that offsprings of parents presenting hyperdynamic circulation (top cardiac index tertile) frequently present elevated BMI, waist/hip ratio and diastolic blood pressure (Palatini et al. 1999 ) as well as high triglycerides (Stern et al. 1992) or thickened subscapular skinfold even as children (Jiang et al. 1995) . This type of finding supports the notion that hemodynamic disturbances have probably set a genetic imprinting translating into metabolic abnormalities.
A major new notion is the accumulating evidence for intergenerational transmission of metabolic syndrome or obesity. It is thus fascinating to note that birth weight, a very important factor as will be seen later, relates to diabetes in grandparents in a U-shaped curve (McCarron et al. 2004.) . Intrauterine growth retardation (IUGR) due to low protein diet during gestation is linked to intergenerational consequences as expressed by "small for gestational age (SGA)" babies (Drake and Walker 2004, Selling et al. 2006 ). The same is seen with elevated glucocorticoid levels in utero (Drake et al. 2005) . Very recent data confirm these findings by showing that it extends at least to F3 generation: these pups are intolerant to glucose if males and have fasting hyperglycemia if females. There seems to be a slow resolution in this transmission if F2 generation is put on a regular diet (Benyshek et al. 2006) . Unfortunately, this is presently not the trend in humans! These exciting data demonstrate that obesity can be programmed, i.e. we might develop diseases due to environmental factors having occurred in one or more upstream generation. This also sets the limits of our comprehension because we usually ignore the anthropometric or life habits characteristics of our ancestors. As a whole we might say that, by definition, investigations are largely biased in obese patients due to the complexity of present metabolic situation and unknown factors inherited either during pregnancy or even long before.
PERINATAL PHYSIOLOGY AND OBESITY
Intensive animal, clinical and epidemiological research over the recent years has shown that both pre-and postdelivery periods are crucial for the development of metabolic and cardiovascular diseases during childhood or adulthood. Interestingly, critical windows are not a matter of weeks or months but usually days! The last week of gestation as well as the first two weeks postpartum are indeed essential for some maturation processes, in particular in the central nervous system and pancreas. The awareness about possible fetal programming of obesity and/or cardiovascular diseases came from the observation that low birth weight (LBW) subjects were at high risk for developing these diseases ). These findings are not universal since a retrospective analysis of 855 children aged 11-13 years found no global association of low birth weight with cardiovascular risk factors, whereas BMI did correlate (Daly et al. 2005) . A plausible explanation for this discrepancy may be found in the prominent role, as will be seen, played by rapid initial and even delayed postnatal weight gain (Eriksson et al. 2004) . One study indeed found that augmented cardiovascular diseases were restricted to low birth weight subjects who presented high BMI in adulthood (Frankel et al. 1996) . A broad study performed in almost 150.000 boys aged 18 years showed also preferential blood pressure increase in low birth weight subjects having experienced postnatal catchup growth (CUG) (Nilsson et al. 1997) . Carotid intima/media thickness was increased in subjects with this type of growth (Oren et al. 2004 ). Young, fit low birth weight adults showed reduced endothelial function, while endothelium-independent function was intact (Goodfellow et al. 1998 , Leeson et al. 2001b ). Children aged 8-13 years have endothelium dysfunction, linked to elevated uric acid levels (Franco et al. 2006 ). Other investigators did not find endothelium dysfunction but an increase in plasma von Willebrand factor as a sign of endothelial lesion (McAllister et al. 1999 ).
Very interestingly vascular defects are found very early in life in low birth weight subjects: while 9 years young children had endothelial dysfunction and a trend toward carotid stiffness (Martin et al. 2000a ), 3 months infants showed limited maximal hyperemia (Goh et al. 2001) . 1-3 months babies born low birth weight had elevated sympathetic tone and reduced activity of the autonomic nervous system (Galland et al. 2006) . A study performed 3 days after delivery in low birth weight babies showed reduced dilatation to acetylcholine but not to heating (Martin et al. 2000b) , which could suggest a defect in mid-sized rather than smallest arteries. All these studies suggest that microvascular defects are present from the beginning of life. Further studies will be necessary to unravel underlying mechanisms, since there is discrepancy as to a reduction -or not -in capillary density (Goh et al. 2001 , Irving et al. 2004 . In low-protein diet intrauterine growth retardation studies, capillary density was normal at delivery but decreased thereafter, lending support to the prominent role of postnatal environmental adaptation (Pladys et al. 2005 ). Capillary recruitment is reduced in low birth weight (Ijzerman et al. 2002) and relates to body weight even in healthy individuals (Serne et al. 2000) . Finally it should be stressed out that, with the progressive rise in knowledge, low birth weight as such is not the real culprit: when small for gestational age subjects are compared with low birth weight preterm ones, only small for gestational age have blunted NOdependent responses (Norman and Martin 2003) . This difference could explain the absence of defects in endothelial function in low birth weight populations (Hermann et al. 2003) . In fact, some authors question the link between low birth weight and cardiovascular diseases (Jones and Nyengaard 1998) . Nowadays small for gestational age seems therefore a more appropriate subpopulation than low birth weight when it is intended to study these topics.
BIRTH WEIGHT, OVERWEIGHT AND OBESITY
Birth weight and metabolic/anthropometric data are numerous and look rather homogeneous. The reader is referred to several very complete reviews on this topic (Cianfarani et al. 1999 , Gluckman and Hanson 2004 , Newsome et al. 2003 , Levy-Marchal and Czernikov 2006 , Ong 2006 . Both low and high birth weight can lead to overweight in adulthood but whereas the former is due to fat accumulation the latter is due to augmented lean mass (Ong 2006) . The ARYA study has documented that low birth weight predicts metabolic syndrome, linked with hypertension and hypertriglyceridemia with an odd ratio of 1.8 (Ramadhani et al. 2006) . Young adults with normal weight but born with low weight had mild hyperglycemia, were glucose intolerant and had slightly elevated blood pressure as well as higher plasma cortisol (Levitt et al. 2000) . Low birth weight, thinness at 2 years and increased BMI after it lead to insulin resistance (Barker 2005) . Prepubertal children born small for gestational age had reduced insulin sensitivity (Veening et al. 2004 ). Already at 1 year of age, infants born small for gestational age have elevated triglyceride and insulin levels (Soto et al. 2003) . At any age between 2 and 47 months, small for gestational age children have more fat (Hediger et al. 1998) . It has been suggested that moderate elevation in insulin levels seen in low birth weight children was due to intrauterine growth retardation rather than to low birth weight itself (Mericq 2006).
Peripheral insulin resistance in small for gestational age individuals is a common finding; although the precise mechanisms must be identified, since clamp studies revealed a defect but the reaction to an oral glucose tolerance test was normal (Veening et al. 2002) . Very few mechanistic data are available, but it was found that modifications typical of insulin resistance at cellular level (reduced PKC activity, GLUT-4 translocation and p85 activation) occurred in low birth weight individuals (Ozanne and Hales 2005) . Another hypothesis could be an augmented passage of glucocorticoids from mother to foetus, programming an increased response of the central nervous system to stress and an increased sensitivity to glucocorticoids in fat cells (Achard et al. 2006 ).
Epigenetic programming has been reviewed recently (Holness and Sugden 2006).
Some authors suggested that not body weight but rather body length (postnatal body growth) might be the most relevant indicator of growth: small for gestational age subjects with adult short stature exhibit elevated sympathetic activity, a likely link to metabolic syndrome (Boguszewski et al. 2004 ).
In order to distinguish between genetically determined, inherited factors and fetal programming leading to low birth weight, some studies have elegantly approached the problem by studying twin populations. These individuals not only have the same genetic background but also have reduced birth weight. One study found that, as adults, low birth weight twins had no augmented risk for metabolic syndrome/diabetes, suggesting also here that low birth weight per se is not harmful (Tuya et al. 2003) . Other studies showed increased risk for abdominal obesity in low birth weight/small for gestational age twins (Hng et al. 2006 , Vaag et al. 2006 ). Intrapair differences in adiponectin levels and endothelial function were reported in young adult, homozygotic twins: this acquired reduction in adiponectin correlated with endothelial dysfunction rather than with obesity (Pietilainen et al. 2006) . It must also be mentioned that a study performed in 50-70 years old low birth weight subjects found a link to truncal (android type) obesity but not abdominal one (Byberg et al. 2000) . This type of investigation would greatly help to understand points which are still obscure due to missing data.
In conclusion, low birth weight as a global term is clearly associated with elevated risks for overweight/ obesity and cardiovascular complications, even at a young age. Clearly, the very last week of gestation is of paramount importance, although caution is recommended because rodents differ from higher mammals or humans in their degree or organ maturation at birth. These and some more specific findings, however, also point to the importance of very early postnatal environmental and nutritional factors.
POSTNATAL WEIGHT GAIN: THE KEY EVENT?
The studies described above clearly demonstrate that the perinatal period can be a key determinant of adult chronic diseases (Hoet et al. 2000) . Since low birth weight can have different origins and is frequently related to problems linked with maternal hemodynamic or hormonal factors, other studies have focused on immediate or early postnatal period.
Indeed it was observed that if poor fetal growth was followed by accelerated postnatal weight gain (so-called "catch-up growth"), fat mass accumulation was more prominent (Ong 2006), resulting in overweight (Stettler et al. 2005 ) and metabolic syndrome (Fagerberg et al. 2004) in adulthood. An elegant study showed that dams subjected to 50% restriction in food intake during the last week of gestation delivered low birth weight pups, which experienced catch-up growth after birth. These animals became intolerant to glucose and obese at 6 months. When low birth weight was not followed by catch-up growth, however, animals behaved like controls (Jimenez-Chillaron et al. 2006) . These findings nicely illustrate the prominent role played by catch-up growth after birth. Sheeps with low birth weight and catch-up growth after birth exhibited increases in both lean and fat mass when adult, but abdominal fat mass had the largest increment (Louey et al. 2005) . Animals subjected to intrauterine growth retardation are born with low birth weight and, due to catch-up growth after birth, recover normal weight within 7 weeks: then weight gain progresses more than in control animals and, at 26 weeks, they present all signs of metabolic syndrome: hyperglycemia, intolerance to glucose, insulin resistance and loss of pancreatic β-cell mass (Simmons et al. 2001 ). In small for gestational age subjects, imme-diate postpartum insulin sensitivity was rather increased but rapidly declined within 3 days, relating to postnatal weight gain (Mericq et al. 2005) . That catch-up growth leads to insulin resistance is also illustrated by a link with polycystic ovary syndrome (DeZegher and Ibanez 2006) . Experimentally this combination even led to premature death in mice (Ozanne and Hales 2005) . Studies showed that postnatal weight gain was the most important determinant of BMI in 7 years young children (Kinra et al. 2005) .
Although the first days following delivery are crucial, catch-up growth over the first 2 years can also lead to these metabolic derangements; it was even suggested that delayed catch-up growth (weight gain between 1st and 2nd years) was more important than the early one for determining adult BMI (Ezzahir et al. 2005) . Here again some authors proposed that linear body growth rather than accelerated weight gain might determine adiposity in growth-retarded infants (Modi et al. 2006 ).
On the vascular side, few data related to catch-up growth are available; however a 4% reduction in flowmediated dilatation was documented, which corresponds to the quantitative effects of smoking on this parameter (Singhal et al. 2004) . Another study showed that those individuals with the earliest catch-up growth (between 1 and 5 years of age) had the highest blood pressure as young adults (Law et al. 2002) . The reader is referred to some pertinent reviews on health problems linked to catch-up growth (Lucas 1998 , Cianfarani et al. 1999 , Kayes and Hindmarsh 2006 , Singhal 2006 .
Mechanistically the link between catch-up growth and adult diseases may be due to decreased thermogenesis. Experimental suppression of thermogenesis induced by semistarvation and isocaloric refeeding leads to catch-up growth, a decrease in skeletal muscle sensitivity to insulin and a concomitant increase in fat with high activity of the fatty acid synthase in adipose tissue (Cettour-Rose et al. 2005 , Dulloo 2006 ). This might be mediated by β 3 -adrenoceptors in the neonatal period (Yeung 2006) . Cafeteria-diet during gestation and prolonged during lactation leads to reduced muscle mass, a potential cause of insulin resistance, since muscle is the main storage site for glucose. In fact, muscle fibre fat content was increased and fat pads were hypertrophied (Bayol et al. 2005 ).
Therefore we are facing a major discovery, which might explain a considerable number of cases of human obesity: gestation (especially the latest period) and early postnatal life may have programmed childhood and adulthood weight increase. This revolutionary view has prompted corresponding studies in order to understand the reasons of this phenomenon. While late gestation epigenetic imprinting can be related to the maternal health state (low protein diet, hypertension, elevated glucocorticoids, etc.), postnatal events do likely relate to (over) feeding. Indeed it is known that fat-rich diet during suckling can lead to elevated blood pressure, endothelial dysfunction and hyperinsulinemia (Khan et al. 2005) and that postnatal saturated fat intake (rather than fat intake as such) is linked to metabolic syndrome (Armitage et al. 2005 , Kalies et al. 2005 . This suggests that overfeeding, either in qualitative (saturated fats) or quantitative terms may exert harmful effects during the first weeks of life, which programmes later development of chronic diseases. Researchers have appropriately addressed these questions by comparing breastfeeding with formula milk feeding and by developing models to induce overfeeding.
POSTNATAL FEEDING: QUALITY AND QUANTITY
Milk formulas and infant foods are frequently rich in linoleic acid, whereby prostacyclin levels and signalling might promote and induce adipose tissue development (Massiera et al. 2003) . In fact, feeding humans during the first week with milk formulas correlated with overweight/obesity (Stettler et al. 2005) . Accelerated weight gain and growth were seen already at 1 year (Oddy et al. 2006) . When breast feeding (BF) was combined with complementary formula foods, however, there was no difference in adiposity at age 5 years (Burdette et al. 2006 ), suggesting that breast-feeding might refrain growth acceleration (Singhal 2006) . In fact, prolonged breast-feeding diminished the risk of overweight (Grummer-Strawn and Mei 2004) and type 2 diabetes (Plagemann and Harder 2005) . However, if the mother was diabetic breast-feeding increased the risks due to modifications in milk composition. Several meta-analysis have been performed to try to give a definitive answer to this vividly debated topic: it was shown that duration of breast feeding was inversely related to the risk of becoming overweight (Harder et al. 2005) but cor-rection for confounding factors reduced the correlative strength , Owen et al. 2005 . A third meta-analysis cautiously concluded that there were no differences between breast and bottle feeding for the development of cardiovascular diseases, but pointed to the weakness of this conclusion (Marin et al. 1994) . Thus, although the dominant impression is in favour of breastfeeding, a definitive conclusion is not available. On the other hand, breast-feeding might also become harmful if prolonged: one study showed reduced arterial distensibility in young adults who were breastfed for more than 4 months (Leeson et al. 2001a) .
Overfeeding is another potential way to ingest excessive lipids. In a series of elegant and carefully designed experimental setups, Plagemann and co-workers (Plagemann 2006) have addressed this question by reevaluating a model where the number of suckling pups is varied in the litter (McCance 1962) . Offsprings rats raised in small litters showed elevated insulin levels at day 15 after birth and higher body weight gain during the suckling period as well as increased blood pressure (Plagemann et al. 1992) . Their susceptibility to the diabetogenic drug streptozotocin was increased, which is reminiscent of what is seen in adult rats fed fructose (N. Wiernsperger, unpublished results). Moreover 11B-HSD1 was increased in fat, which represents a potential link to cardiovascular disturbances (Morris et al. 2005) . Rats grown in small litters after birth are heavier at 40 and 80 days after birth and exhibit more epididymal and retroperitoneal fat (Mozes et al. 2004 ). Such animals have greatly increased visceral fat, glucocorticoid signalling and a moderate increase in corticosterone levels (Boullu-Ciocca et al. 2005 ). Thus this model, which concentrates on immediate postnatal period apparently exactly mimicks what is known from other experimental and clinical observations. However, also here potential differences between rodents and humans should be taken into consideration, due to differences in perinatal organ maturation. Nevertheless this "simple" model should be subjected to prioritizing investigations because it is unbiased by prenatal and hereditary influences and would allow to follow-up the development of obesity and cardiovascular disturbances over time as well as over generations. It also represents a unique situation to study the potential implication of the microcirculation as a cause of delayed development of these diseases.
A PARTICULAR ROLE FOR LEPTIN?
This hormone has attracted much interest during the past decade. Leptin concentration is increased in obesity and its link to appetite saturation was hypothesized. Since leptin has also clear-cut effects on the vascular system, this hormone represented an exquisite candidate to explain the genesis of obesity and cardiovascular diseases (Singhal 2005) . Leptin is atherogenic and exerts many negative cardiovascular effects such as endothelial dysfunction, oxidative stress, stimulation of inflammation and platelet aggregation as well as hypertrophy or proliferation of smooth muscle cells (Beltowski 2006) . Ob/ob mice, which lack the leptin gene, are protected against atherosclerosis and, conversely, administration of leptin to such mice produces atherosclerotic lesions (Konstantinides et al. 2001) . Leptin also activates the sympathetic nervous system, acting on cardiac and vascular contractility (Ren 2004) . At levels found in obesity, but not at normal concentrations, leptin reduces coronary NO-dependent vasodilatation (Knudson et al. 2005) . At the microcirculatory level, similar to adiponectin, leptin enhances dilatation to heat (Tigno et al. 2003) . In the general population leptin independently correlates with waist/hip ratio, insulin resistance, IL-6, C-reactive protein, triglycerides, plasma viscosity, fibrinogen, von Willebrand factor and tPA but not with glycemia, cholesterol or blood pressure (Wannamethee et al. 2006) . Leptin might promote lipotoxicity in skeletal muscle and pancreatic β-cells, thereby leading to insulin resistance and subsequently to cardiovascular modifications (Mark et al. 2004 ). However, not all studies agree about the role of leptin in the linkage between obesity and cardiovascular disease risk markers (Gomez-Ambrosi et al. 2006) or endothelial function (Rahmouni and Haynes 2005) .
Concerning the perinatal period, data available look complex. It was proposed that, due to leptin-or insulinresistance, leptin concentrations would increase weight gain. Mice subjected to intrauterine growth retardation during gestation showed a postnatal leptin increase and normal mice given leptin postnatally exhibited accelerated weight gain (Yura et al. 2005) . Postnatal overfed rats became resistant to leptin and exhibited a 7-fold increase in plasma leptin levels. However hyperleptinemia was not totally responsible for the resistance to the hormone (Schmidt et al. 2001) . Very young obese children have increased leptin in the blood, less adiponectin and elevated C-reactive protein (Valle et al. 2005) . Breastfed children have lower leptin levels than those fed with milk formula (Singhal et al. 2002) . These data are reminiscent of what was described in previous paragraphs and suggest that higher leptin after birth might promote overweight/obesity and cardiovascular disturbances. During pregnancy leptin is also involved in growth: small for gestational age children have reduced leptin in the umbilical cord blood (Martinez-Cordero et al. 2006) . In animals submitted to intrauterine growth retardation and postnatal high fat diet, leptin administration during both pregnancy and lactation prevented obesity and insulin resistance, an effect, which might be explained by an inhibition of suppression of 11B-HSD2 (Stocker et al. 2005) . Another study showed that leptin administration from day 3-13 after birth slowed down the weight gain and normalized caloric intake (Vickers et al. 2005 ). Another approach used intracerebroventricular injection of adenovirus encoding for the leptin gene in adult female rats: these dams produced normal numbers of pups with lower weight during gestation and lactation. Their offsprings had reduced body weight, and this effect was sustained for 3 months, showing an imprinting phenomenon (Lecklin et al. 2005) .
As a whole it appears that there is evidence for an implication of leptin in critical perinatal events. However data presently available are partly contradictory and it seems that pre-and postnatal leptin might have different -if not opposing -effects. Clearly further studies are needed to define its real importance.
CONCLUSION
Recent experimental, clinical and epidemiological investigations have delivered completely new insights into obesity, both on its origins and its relations to diabetes and cardiovascular diseases. To a large extent these new data challenge classical concepts about a "simple" relation of overweight with these diseases, allowing to predict that in a hopefully near future obesity will be considered in practice very differently from today. Access to well-documented patient's dossiers will favour integration of genetic as well as epigenetic aspects in order to evaluate more precisely true risks, when data such as family history (intergenerational transmission) or gestational and perinatal events will be available. It is likely that not body weight per se but fat distribution centering on the presence of even modest abdominal obesity will become the main criterion for differential diagnosis and new targeted treatments.
The role played by the microcirculation in the evolution towards obesity from early life to childhood and adulthood is still largely hypothetical. However physiological investigations about the connexion between this part of the circulation and metabolic events in surrounding tissues on one hand, availability of elegant experimental models nicely mimicking human situation in early life on the other hand, represent a solid basis for identifying to which extent the microcirculation is causally involved. (4) várias décadas dos fatores genéticos e epi-genéticos em acú-mulo de gordura. Os modelos experimentais disponíveis devem servir para responder essa questão extremamente relevante. 
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